Simtra BioPharma Solutions is advancing a dual-continent expansion aimed at boosting capacity for sterile injectable drugs.

To develop monoclonal antibody biomanufacturing innovations and produce an anti-filovirus Medical Countermeasure.

Merck has reached an agreement with Dr. Falk Pharma to discontinue an existing contract concerning co-development and co-commercialization rights in certain territories for MK-8690.

Boehringer Ingelheim and CDR-Life have announced a new global licensing agreement to develop CDR-Life’s CDR111 for autoimmune diseases.

Kaigene Inc. has entered into an exclusive global licensing agreement with Celltrion Inc. for two of Kaigene's nonclinical-stage assets, KG006 and KG002.

Strategic financing will advance development of sac-TMT while Merck continues to progress its expansive pipeline.

Magnet Biomedicine, a biopharmaceutical company, has appointed Bharat Reddy, Ph.D., as its new Chief Business Officer.

G-Rex based manufacturing process to produce gene-modified regulatory T cell (Treg) therapies for autoimmune disorders ...

Sotio Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, promoted Vivi Boura, M.D., Ph.D., an oncologist with experience leading the clinical development of novel cancer therapies ...

The Merck Foundation has launched the Collaborative for Equity in Cardiac Care, a $22 million, five-year initiative.

Ardena, a CDMO and CRO, has appointed Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer.

Circle Pharma Inc., a clinical-stage biopharmaceutical company, has appointed Rob Lauzen as Chief Financial Officer (CFO).